Cannabis products may undermine effectiveness of cancer drugs

A new study finds that cannabis-derived compounds can interfere with how platinum-based chemotherapy drugs reach cancer cells, potentially reducing treatment effectiveness. The finding has significant implications for oncology practice and patient counseling, as cannabis use becomes more common and socially accepted.

Originaltitel: Cannabis-derived products antagonize platinum drugs by altered cellular transport